$0.77
0.0358[4.88%]
At close: Apr 23
$0.77
0[0.00%]
After Hours: 7:41PM EDT
Citius Pharma
(NASDAQ:CTXR)Citius Pharma Stock (NASDAQ:CTXR), Earnings Estimates, EPS, and Revenue
Citius Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-0.050
Quarterly Revenue Estimate
$14.8M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Citius Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | PM | CTXR | Q2 | -$0.07 | -$0.05 | — | — | $0.00 | $14.81M | — | — | Get Alert |
| 02/14/2024 | PM | CTXR | Q1 | -$0.02 | — | -$0.06 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/29/2023 | PM | CTXR | Q4 | -$0.05 | — | -$0.07 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2023 | PM | CTXR | Q3 | -$0.06 | — | -$0.06 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/12/2023 | PM | CTXR | Q2 | -$0.05 | -$0.03 | -$0.07 | -133.33% | $0.00 | — | $0.00 | — | Get Alert |
| 02/10/2023 | PM | CTXR | Q1 | -$0.06 | — | -$0.02 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/22/2022 | PM | CTXR | Q4 | -$0.03 | -$0.04 | -$0.05 | -25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | PM | CTXR | Q3 | -$0.05 | -$0.05 | -$0.06 | -20.00% | $0.00 | — | $0.00 | — | Get Alert |
| 05/12/2022 | PM | CTXR | Q2 | -$0.04 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
| 02/10/2022 | PM | CTXR | Q1 | -$0.15 | -$0.06 | -$0.06 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 12/15/2021 | PM | CTXR | Q4 | -$0.07 | -$0.04 | -$0.03 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2021 | AM | CTXR | Q3 | -$0.11 | -$0.06 | -$0.05 | 16.67% | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2021 | AM | CTXR | Q2 | -$0.13 | -$0.06 | -$0.04 | 33.33% | $0.00 | — | $0.00 | — | Get Alert |
| 02/11/2021 | PM | CTXR | Q1 | -$0.15 | — | -$0.15 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/16/2020 | PM | CTXR | Q4 | — | — | -$0.07 | — | — | — | $0.00 | — | Get Alert |
| 08/14/2020 | AM | CTXR | Q3 | — | — | -$0.11 | — | — | — | $0.00 | — | Get Alert |
| 05/14/2020 | AM | CTXR | Q2 | — | — | -$0.13 | — | — | — | $0.00 | — | Get Alert |
| 02/13/2020 | AM | CTXR | Q1 | — | — | -$0.15 | — | — | — | $0.00 | — | Get Alert |
| 12/16/2019 | AM | CTXR | Q4 | — | — | -$0.16 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Citius Pharma (NASDAQ:CTXR) reporting earnings?
Citius Pharma (CTXR) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Citius Pharma (NASDAQ:CTXR)?
The Actual EPS was $-0.06, which missed the estimate of $0.00.
What were Citius Pharma’s (NASDAQ:CTXR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.